612526-11-1

Basic information

• Product Name: XHe-II-053
• Synonyms: XHe-II-053
• CAS NO: 612526-11-1
• Molecular Weight: 355.396
• Mol File: 612526-11-1.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: XHe-II-053(CAS DataBase Reference)
• NIST Chemistry Reference: XHe-II-053(612526-11-1)
• EPA Substance Registry System: XHe-II-053(612526-11-1)

Safety Data

• Hazardous Substances Data: 612526-11-1(Hazardous Substances Data)

Upstream product

• 612526-08-6 ethyl 8-trimethylsilylacetylenyl-6-phenyl-4H-benzo[f]imidazo[1,5-a][1,4]diazepine-3-carboxylate 

Downstream Products

• 612526-74-6 5-(8-ethynyl-6-phenyl)-4H-benzo-[f]-imidazo-[1,5-a]-[1,4]-diazepine-3-ethyl-1,2,4-oxadiazole 
• 1413433-39-2 EMJ-I-026 
• 1413432-97-9 YT-III-31 
• 1140967-95-8 (Z)-8-ethynyl-N-(2-methoxyethyl)-6-phenyl-4H-benzo[f]imidazo[1,5-a][1,4]diazepine-3-carboxamide 

Relevant articles and documents

SELECTIVE ANTICONVULSANT AGENTS AND THEIR USES

In preferred embodiments, the present invention provides methods of treatment and pharmaceutical compositions for the suppression, alleviation and prevention of seizures. The preferred embodiments of the present invention further relate to methods of treatment and pharmaceutical compositions using benzodiazepine derivatives that provide suppression, alleviation and prevention of seizures with reduced sedative and ataxic side effects.

ANXIOLYTIC AGENTS WITH REDUCED SEDATIVE AND ATAXIC EFFECTS

Orally active benzodiazepine derivatives and their salts are disclosed. These compounds and their salts have anxiolytic and anticonvulsant activity with reduced sedative/hypnotic/muscle relaxant/ataxic effects.